maxcyte

MaxCyte, Inc.

MaxCyte is a cell-engineering company that provides technologies to support the development of cell-based therapeutics, from discovery to commercialization. They focus on enabling non-viral cell engineering using their Flow Electroporation® technology, which allows for the efficient and scalable modification of cells.

Content by MaxCyte, Inc.

Rethinking cell-based screening for faster therapeutic discovery
Available on Demand
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Shaping Science graphic featuring the question “How can labs become truly sustainable?” and a photo of James Connelly, Chief Executive Officer of My Green Lab.
Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.
A gloved laboratory technician selects a labeled blood sample tube from a rack containing multiple color-coded collection tubes.
Analytical performance begins long before a sample reaches the instrument, making sample preparation one of the most important determinants of data quality.
Gloved researcher transferring liquid into a microplate using a multichannel pipette.
Discover practical strategies to improve pipetting accuracy, reproducibility, ergonomics, and instrument performance across diverse laboratory workflows.